Critical Pressure Limited

Critical Pressure Limited

Trading as: Critical Pressure
#10826367 Active

Critical Pressure is a provider of drugs designed to treat to treat vascular dysfunction and shock. The company's technology has the potential to change clinical practice without the potentially harmful effects of excess fluid administration and toxicities associated with the currently available catecholamine-based vasoactive agents, providing the possibility of supportive therapy during the critical period of haemodynamic compromise.

Founded: 20/06/2017
Industries: Research and experimental development on biotechnology

Financial Snapshot

Last accounts made up to 30 June 2024
Next accounts due 31 March 2026 (10 months)
Cash in Bank £246,520
↓ -57%
Total Liabilities £1,818
↓ -80%
Employees 2
↑ 0%

Directors

Role:
Research Scientist
Appointed:
20/06/2017
Nationality:
British
Age:
59 years

People with Significant Control

Professor James Mitchell Leiper
Nature of Control:
Ownership Of Shares 25 To 50 Percent
Notified On:
24/11/2021
Nationality:
British
Jun 2023Jun 2022Jun 2021
Income Statement
Turnover
Export Revenue
Sales
Other Operating Income
Other Operating Items
Cost of Sales
Raw Materials & Consumables
Gross Profit
Admin Expenses
Other Operating Charges
Depreciation
R&D Expenses
Operating Profit
EBITDA
Financial Revenue
Financial Expenses
Financial Profit/Loss
Interest Paid
Extraordinary Revenue
Extraordinary Expenses
Net Extraordinary Items
Pre-Tax Profit
Tax
Profit After Tax
Retained Profit
Balance Sheet
Non-Current Assets
Intangible Assets
Tangible Fixed Assets
Other Non-Current Assets
Current Assets
Stock
Debtors
Cash in Hand
Other Current Assets
Called Up Share Capital
P&L Account Reserve
Shareholder Funds
Other Shareholder Funds
Provisions
Long Term Debt
Creditors (> 1 year)
Other Non-Current Liabilities
Short Term Debt
Creditors
Creditors (< 1 year)
Other Current Liabilities
Key Metrics
Net Assets
Net Current Assets
Total Assets Less Current Liabilities
Working Capital
Enterprise Value
Added Value
Cashflow Before D&A
Other Information
Staff Costs
Number of Employees
9 shareholders available
Shareholder 1
Shares:
Percentage:
Filing Date:
Shareholder 2
Shares:
Percentage:
Filing Date:
Shareholder 3
Shares:
Percentage:
Filing Date:

Charges

No charges registered

Properties

No property information available

0 issuances recorded

Total Amount Raised (Valid Issuances)

Shares Issued (Valid Issuances)

Date CLASS
Shares Issued:
Price Per Share:
Amount Raised:
Filing:
Date CLASS
Shares Issued:
Price Per Share:
Amount Raised:
Filing:

Grants

No grant information available

Group Structure

No group structure information available

Government Council Contracts Beta

No council contracts found

Company Filings

27/01/2025 Accounts

Accounts With Accounts Type Total Exemption Full

21/06/2024 Confirmation Statement

Confirmation Statement With Updates

19/06/2024 Confirmation Statement

Confirmation Statement With No Updates

26/03/2024 Accounts

Accounts With Accounts Type Total Exemption Full

12/12/2023 Officers

Termination Director Company With Name Termination Date

20/06/2023 Confirmation Statement

Confirmation Statement With No Updates

20/06/2023 Persons With Significant Control

Withdrawal Of A Person With Significant Control Statement